OTTAWA — Canada is signing deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to procure millions of doses of their experimental COVID-19 vaccines.
Procurement Minister Anita Anand is announcing the deals this morning in Toronto, which will see Canada get access to the vaccines if they prove to be both safe and effective.
Both companies began Phase 3 clinical trials of their vaccine candidates in the last week, large-scale tests to determine how well the vaccines work.
Earlier in July both Pfizer and Moderna reported positive results from smaller trials.
The Phase 3 trials will both test the vaccines on 30,000 people, and results are expected in the fall.
Canada’s chief public health officer Dr. Theresa Tam warned Tuesday about expecting a vaccine to provide a quick end to the pandemic, saying they provide hope but likely no silver bullet for the novel coronavirus.
This report by The Canadian Press was first published Aug. 5, 2020.
The Canadian Press
